Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines

Summary

22 asthmatics, in which mepolizumab was to be started, gave permission for inclusion and were followed up prospectively. Clinical and lung functional data, sputum analyses and cytokine measurements were analyzed.

Timeline

Start

2016-09-01

Primary completion

2018-05-01

Completion

2019-03-01

Drugs

Indications